Method of determining interactions with PDZ-domain polypeptides

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

06942981

ABSTRACT:
Methods are provided for determining interactions between multiple PDZ-domain polypeptides and PDZ Ligand Proteins.

REFERENCES:
patent: 5632994 (1997-05-01), Reed et al.
patent: 5747245 (1998-05-01), Reed et al.
patent: 5863898 (1999-01-01), Goli et al.
patent: 5876939 (1999-03-01), Reed et al.
patent: 5958731 (1999-09-01), Yue et al.
patent: 5976819 (1999-11-01), Finkel et al.
patent: 6174702 (2001-01-01), Lal et al.
patent: 2002/0058607 (2002-05-01), Sato et al.
patent: 2002/0147306 (2002-10-01), Lin et al.
patent: 2003/0049695 (2003-03-01), Lu et al.
patent: 2003/0203414 (2003-10-01), Sato et al.
patent: 2273622 (2000-12-01), None
patent: WO 98/05347 (1998-02-01), None
patent: WO 98/23781 (1998-06-01), None
patent: WO 98/40407 (1998-09-01), None
patent: WO 99/03974 (1999-01-01), None
patent: WO 99/07846 (1999-02-01), None
patent: WO 00/15794 (2000-03-01), None
patent: WO 00/31124 (2000-06-01), None
patent: WO 00/48002 (2000-08-01), None
patent: WO 00/69896 (2000-11-01), None
patent: WO 00/69897 (2000-11-01), None
patent: WO 00/69898 (2000-11-01), None
patent: WO 02/31512 (2002-04-01), None
patent: WO 02/42422 (2002-05-01), None
patent: WO 03/014303 (2003-02-01), None
Gee et al. The Journal of Neuroscience, Jan. 1, 1998, 18(1):128-137.
Coligam et al. Current Protocols in Immunology, 1991, pp. 2.03-2.1.9.
U.S. Appl. No. 07/724,553, Lu et al.
U.S. Appl. No. 09/722,069, Lu et al.
Altin, J. and Sloan, E. “The role of CD45 and CD45-associated molecules in T cell activation”Immunology and Cell Biology, 1997, pp. 430-445, vol. 75.
Bals, R. et al. “Augmentation of Innate Host Defense by Expression of a Cathelicidin Antimicrobial Peptide”,Infection and Immunity, Nov. 1999, pp. 6084-6089, vol. 67, No. 11.
Barclay, A., et al., “The Leukocyte Antigen Factsbook”,Harcourt Braces&Company, p. 363, (1997).
Bruyns, E. et al. “Identification of the Sites of Interaction between Lyphocyte Phosphatase-associated Phophoprotein (LPAP) and CD45”,Journal of Biological Chemistry, Dec. 29, 1996, pp. 31372-31376, vol. 270, No. 52, U.S.A.
Cherukuri, A. et al. “Floating the raft hypothesis: lipid rafts play a role in immune cell activation”,Immunity, Jun. 2001, pp. 657-660, vol. 14, Cell Press.
Ding, I. Et al., “Biochemical and Functional Analysis of Mice Deficient in Expression of the CD45-Associated Phosphoprotein LPAP”,European Journal of Immunology, 29(12):3956-61 (1999).
Doyle, D. A., et al., “Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ”,Cell, 85(7):1067-76, (1996).
Faulkner, G. et al. “A New Z-band Alternatively Spliced PDZ-motif Protein.”The Journal of Cell Biology, Jul. 26, 1999; pp. 465-475, vol. 146, No. 2.
Gardiol, D. et al. “Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation”,Oncogene, 18(40):5487-5496, (1999).
Gee., S.H., et al., “Cyclic Peptides as Non-carboxyl-terminal Ligands of Syntrophin PDZ Domains”,The Journal of Biological Chemistry, 273(34):21980-21987, (1998).
Hanada, T., et al., “Human Homologue of theDrosophilaDiscs Larger Tumor Suppressor Binds to p56lckTyrosine Kinase and Shaker Type Kv1.3 Potassium Channel in T. Lymphocytes”,The Journal of Biological Chemistry, 272(43):26899-26904, (1997).
Kiyono, T. et al. “Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of theDrosophiladiscs large tumor suppressor protein”,Proc. Natl. Acad. Sci., Oct. 1997, pp. 11612-11616, vol. 94, U.S.A.
Kobayashi, I., et al., “Identification of an Autoimmune Enteropathy-related 75-kilodalton Antigen”,Gastroenterology, Oct. 1999, pp. 823-830, vol. 17, No. 4.
Maekawa, K., et al., “Association of Protein-Tyrosine Phosphatasee PTP-BAS with the Transcription-factor-inhibitory Protein IκBα Through Interaction Between the PDZ1 Domain and Ankyrin Repeats”,Biochemical Journal, 337(2):179-187, (1999).
McKusick, Victor A.; OMIM Database entry entitled, ‘147138 Fc Fragment of IgE, High Affinity I, Receptor for, Beta Subunit; FCER1B’, www.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?147138, Aug. 27, 1992.
Nagase, T. et al. “Prediction of the Coding Sequence of Unidentified Human Genes. V1. The Coding Sequences of 80 New Genes (KIAA0201-KIAA0280) Deduced by Analysis of cDNA Clones from Cell Line KG-1 and Brain”,DNA Research, 1996, pp. 321-329, vol. 3.
Nagase, T. et al. “Prediction of the Coding Sequence of Unidentified Human Genes. V1. The Coding Sequences of 80 New Genes (KIAA0201-KIAA0280) Deduced by Analysis of cDNA Clones from Cell Line KG-1 and Brain (Supplement)”,DNA Research, 1996, pp. 341-354, vol. 3, Supplement.
Nishihara, H. et al, “Non-adherent cell-specific expression of DOCK2, a member of the human CDM-family proteins”,Biochimica et Biophysica Acta, 1999, pp. 179-187, Elsevier Publishing.
Nishihara, H. “Analysis of Hematopoietic Cell Specific Protein, M-DOCK”, Hokkaido Igaku Zasshi, Mar. 1999, pp. 157-166, vol. 74, No. 2.
Patel, V. et al., “A Molecular Framework for 2-Step T Cell Signaling: Lck Src Homology 3 Mutations Discriminate Distinctly Regulated Lipid Raft Reorganization Events”,Journal of Immunology, 166(2):754-64 (2001).
Rasooly, Rebekah S.; OMIM Database entry entitled, “603122 Dedicator of Cytokinesis 2; Dock 2” www.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?603122, Oct. 12, 1998.
Reynaud, C. et al., “The PDZ Protein TIP-1 Interacts with the Rho Effector Rhotekin and Is Involved in Rho Signaling to the Serum Response Element”,The Journal of Biological Chemistry, 275(43):33962-33968, (2000).
Rousset, R., et al., “The C-terminus of the HTLV-1 Tax oncoprotein mediates interaction with the PDZ domain of cellular proteins”Oncogene, 16(5):643-54, (1998).
Saras, J., et al., “PDZ Domains Bind Carboxy-Terminal Sequences of Target Proteins”,Tibs Trends in Biochemical Sciences, en, Elsevier Publication, Cambridge, 21(12):455-458, (1996).
Schepens, J., et al., “The Neuronal Nitric Oxide Synthase PDZ Motif Binds to -G(D.E)XV Carboxy Terminal Sequences”,Febs Letters, 409(1-2):53-56, (1997).
Schraven, Burkhart et al. “LPAP, a Novel 32-kDa Phosphoprotein That Interacts with CD45 in Human Lymphocytes”,J. Biological Chemistry, Nov. 18, 1994; pp. 29102-29111, vol. 269, No. 46.
Shibuya, A., et al., “DNAM-1 A Novel Adhesion Molecule Invovled in the Cytolytic Function of T Lymphocytes”,Immunity, 4:573-581, (1996).
Shibuya, A., et al., “Protein Kinase C is Involved in the Regulation of Both Signaling and Adhesion Mediated by DNAX Accessory Molecule-1 Receptor”,The Journal of Immunology, 161:1671-1676, (1998).
Shibuya, K., et al., “Physical and Functional Association of LFA-1 with DNAM-1 Adhesion Molecule”,Immunity, 11:615-623, (1999).
Suzuki, T., et al., “Tax oncoprotein of HTLV-1 binds to the human homologue ofDrosophiladiscs large tumor suppressor protein, hDLG, and perturbs its function in cell growth control”,Oncogene, 18(44):5967-72, (1999).
Vallenius, T. et al. “CLP-36 PDZ-LIM Protein Associates with Nonmuscle alpha-Actinin-1 and alpha-Actinin-4.”The Journal of Biological Chemistry, Apr. 14, 2000; pp. 11100-11105, vol. 275, No. 15.
Wechsler, A. et al. “Brain Spectrin binding to the NMDA receptor is regulated by phosophorylation, calcium and calmodulin.”The EMBO Journal, 1998, pp. 3931-3939, vol. 17, No. 14.
Xia, H. et al. “Actinin-associated LIM Protein: Identification of a Domain Interaction between PDZ and Spectrin-like Repeat Motifs”,The Journal of Cell Biology, Oct. 1997, pp. 507-515, vol. 139, No. 2.
Yanagisawa, J., et al., “The Molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptos

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of determining interactions with PDZ-domain polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of determining interactions with PDZ-domain polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of determining interactions with PDZ-domain polypeptides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3437340

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.